| Thursday, July 01, 2004 |
| 12:00:00 PM |
|
Bldg 549 Auditorium |
| |
The Secret of Life--The race to discover the structure of DNA is depicted in this program
|
Details
|
| Tuesday, July 06, 2004 |
| 8:30:00 AM |
Ronald E. Gress, MD |
Bldg 10 Lipsett |
| |
The Interface of Cancer Immunotherapy and Chemotherapy
|
Details
Series
|
|
| 9:00:00 AM |
Kunio Nagashima |
Bldg 549 Auditorium |
| |
Principles and Application of Scanning and Transmission Electron Microscopy (SEM and TEM)
|
Details
Series
|
|
| 12:00:00 PM |
Tim Hoover |
Bldg 549 Auditorium |
| |
Existence of an Extracellular Pathogen: Anthrax Revisited
|
Details
Series
|
| Wednesday, July 07, 2004 |
| 3:30:00 PM |
Dr. Chris Michejda |
Bldg 45 Natcher Rm. H |
| |
Cell Surface Proteins as Targets for Cancer Therapy
|
Details
Series
|
| Thursday, July 08, 2004 |
| 12:00:00 PM |
|
Bldg 549 Auditorium |
| |
Playing God--The controversy that is genetic engineering is the focus of this program
|
Details
|
| Tuesday, July 13, 2004 |
| 8:30:00 AM |
Andrew von Eschenbach, MD |
Bldg 10 Lipsett |
| |
Progress Toward Eliminating the Suffering and Death Due to Cancer
|
Details
Series
|
|
| 12:00:00 PM |
Dave Fritz |
Bldg 549 Auditorium |
| |
Development of a Rodent Model in the Study of Pathogenic Bacteria
|
Details
Series
|
| Thursday, July 15, 2004 |
| 11:00:00 AM |
Zygmunt K. Gryczynski |
Bldg 549 Conf. Rm B |
| |
Surface Plasmon-Coupled Emission: Novel Approach to Study Molecular Interactions
|
Details
|
|
| 12:00:00 PM |
|
Bldg 549 Auditorium |
| |
The Human Race--The Human Genome Project and its complicated progress are discussed
|
Details
|
| Tuesday, July 20, 2004 |
| 8:30:00 AM |
Steven A. Rosenberg, PhD, MD |
Bldg 10 Lipsett |
| |
The Development of Cell Transfer Immunotherapy for Patients with Cancer
|
Details
Series
|
|
| 9:00:00 AM |
Ruth Redman |
Bldg 549 Auditorium |
| |
CANCELLED--Movement of Neural Tumor Cells in Two and Three Dimensions
|
Details
Series
|
|
| 10:30:00 AM |
Dr. Thorfinnur Gunnlaugsson |
Bldg 549 Auditorium |
| |
Lanthanide Macrocyclic Complexes and Conjugates as Luminescent Probes and Synthetic Ribonucleases
|
Details
|
|
| 12:00:00 PM |
Nancy Colburn |
Bldg 549 Auditorium |
| |
Molecular Targets for Cancer Prevention
|
Details
Series
|
|
| 2:00:00 PM |
POSTER AUTHORS: T.P. Conrads1, T.D. Veenstra1,S.K. Keay2, Z. Szekely3, J.J. Barchi4, C.-O. Zhang2, K.R. Koch2 and C.J. Michejda3--1Laboratory of Proteomics and Analytical Technologies, SAIC-Frederick, Inc, Frederick, MD;2Division of Infectious Diseases, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD; 3Molecular Aspects of Drug Design Section, Structural Biophysics Laboratory,CCR, NCI, Frederick, MD; 4Laboratory of Medicinal Chemistry, CCR, NCI, Frederick, MD--SEMINAR Speaker: Peter Harrsch, Bruker Daltonics, Lansdale, PA |
Bldg 549 Auditorium |
| |
POSTER: Characterization of an Antiproliferative Factor from Interstitial Cystitis Patients--The Poster is available for viewing in the 549 Lobby from 9AM until 3:15 PM and the presenting author will be available following the seminar---SEMINAR: Automation for Proteomics: LC/MS/MS or LC-MALDLI TOF/TOF Solutions
|
Details
Series
|
| Thursday, July 22, 2004 |
| 12:00:00 PM |
|
Bldg 549 Auditorium |
| |
Curing Cancer--Fighting cancer by studying its DNA is the central idea in this program
|
Details
|
| Friday, July 23, 2004 |
| 2:00:00 PM |
Dr. David Tarin |
Bldg 50, Rm 1227 |
| |
Gene Expression and Tumor-Host Cell Interactions in Cancer Metastasis
|
Details
|
| Tuesday, July 27, 2004 |
| 8:30:00 AM |
Elias A. Zerhouni, MD |
Bldg 10 Lipsett |
| |
Future of Medical Imaging
|
Details
Series
|
|
| 12:00:00 PM |
Tom Conrads |
Bldg 549 Auditorium |
| |
An Introduction to Proteomics and Its Applications
|
Details
Series
|
| Thursday, July 29, 2004 |
| 12:00:00 PM |
|
Bldg 549 Auditorium |
| |
Pandora's Box--James Watson's controversial vision of DNA's future completes the series
|
Details
|
|
| 3:00:00 PM |
Waun Ki Hong, M.D. |
Lister Hill Auditorium |
| |
Convergence of Molecular Targets for Cancer Prevention and Therapy
|
Details
|
|
